About: Reappraisal on pharmacological and mechanical treatments of heart failure

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Reappraisal on pharmacological and mechanical treatments of heart failure Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Reappraisal on pharmacological and mechanical treatments of heart failure
Creator	Gu, Ning Liang, Bo Zhao, Yu-Xiu Liao, Hui-Ling Zhang, Xiao-Xiao
source	PMC
abstract	Heart failure (HF) is a highly frequent disorder with considerable morbidity, hospitalization, and mortality; thus, it invariably places pressure on clinical and public health systems in the modern world. There have been notable advances in the definition, diagnosis, and treatment of HF, and newly developed agents and devices have been widely adopted in clinical practice. Here, this review first summarizes the current emerging therapeutic agents, including pharmacotherapy, device-based therapy, and the treatment of some common comorbidities, to improve the prognosis of HF patients. Then, we discuss and point out the commonalities and areas for improvement in current clinical studies of HF. Finally, we highlight the gaps in HF research. We are looking forward to a bright future with reduced morbidity and mortality from HF.
has issue date	2020-05-06(xsd:dateTime)
bibo:doi	10.1186/s12933-020-01024-5
has license	cc-by
sha1sum (hex)	863b6241fc4d73f6290ebc84f1fc9baee2dc7e5b
schema:url	https://doi.org/10.1186/s12933-020-01024-5
resource representing a document's title	Reappraisal on pharmacological and mechanical treatments of heart failure
has PubMed Central identifier	PMC7202267
schema:publication	Cardiovasc Diabetol
resource representing a document's body	covid:863b6241fc4d73f6290ebc84f1fc9baee2dc7e5b#body_text
is schema:about of	named entity 'morbidity' named entity 'developed' named entity 'reduced' named entity 'therapy' named entity 'pharmacological' named entity 'MORBIDITY' named entity 'HIGHLY' named entity 'AREAS' named entity 'PATIENTS' named entity 'GAPS' named entity 'DEFINITION' named entity 'highly' named entity 'summarizes' named entity 'improvement' named entity 'prognosis' named entity 'therapeutic' named entity 'Here' named entity 'mechanical' named entity 'prognosis' named entity 'clinical practice' named entity 'morbidity' named entity 'pharmacotherapy' named entity 'clinical studies' named entity 'bright future' named entity 'heart failure' named entity 'morbidity' named entity 'enalapril' named entity 'cardiac performance' named entity 'quality of life' named entity 'current source' named entity 'dipeptidyl peptidase-4 inhibitor' named entity 'cardiovascular disease' named entity 'Patiromer' named entity 'levosimendan' named entity 'BNP' named entity 'Mortality rates' named entity 'T2DM' named entity 'HFpEF' named entity 'intravenous' named entity 'prognosis' named entity 'spironolactone' named entity 'SGLT' named entity 'renal function' named entity 'B-type natriuretic peptide' named entity 'iron deficiency anaemia' named entity 'blood pressure' named entity 'clinical diagnosis' named entity 'T2DM' named entity 'ivabradine' named entity 'LVAD' named entity 'valsartan' named entity 'intravenous infusion' named entity 'levosimendan' named entity 'spironolactone' named entity 'tolvaptan' named entity 'Linagliptin' named entity 'Eplerenone' named entity 'N-terminal' named entity 'T2DM' named entity 'EPHESUS' named entity '2, 7' named entity 'clinical trial' named entity 'stroke' named entity 'prognosis' named entity 'NT-proBNP' named entity 'kidney disease' named entity 'valve repair' named entity 'maintenance dose' named entity 'incidence of death' named entity 'cardiovascular' named entity 'cardiovascular' named entity 'T2DM' named entity 'spironolactone' named entity 'embolism' named entity 'DANISH' named entity 'chronic obstructive pulmonary disease' named entity 'refractory' named entity 'BNP' named entity 'prospective studies'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software